Cargando…

Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial

BACKGROUND: Regarding the COVID-19 pandemic, potential therapeutic agents are being evaluated almost every day. Ciclosporin, a calcineurin inhibitor, is characterized by beneficial antiviral and immunomodulatory effects. The present study aimed to evaluate the efficacy of ciclosporin in managing COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barati, Saghar, MohammadReza Hashemian, Seyed, Tabarsi, Payam, Abedini, Atefeh, Ashrafzadeh, Mahshid, Haseli, Sara, Abtahian, Zahra, Yousefian, Sahar, Dastan, Alireza, Sobhanian, Ali, Dastan, Farzaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332739/ https://www.ncbi.nlm.nih.gov/pubmed/34426105 http://dx.doi.org/10.1016/j.intimp.2021.108043

Ejemplares similares

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
por: Yousefian, Sahar, et al.
Publicado: (2021)

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form
por: Tabarsi, Payam, et al.
Publicado: (2021)

Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
por: Fakharian, Atefeh, et al.
Publicado: (2021)

Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021)

Study of the Effects of Melatonin on Sleep Disorders in Pulmonary Sarcoidosis Patients
por: Feizabadi, Faezeh, et al.
Publicado: (2023)

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient
por: Fakharian, Atefeh, et al.
Publicado: (2022)

IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients
por: Tabarsi, Payam, et al.
Publicado: (2021)

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
por: Jamaati, Hamidreza, et al.
Publicado: (2021)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital
por: Jamaati, Hamidreza, et al.
Publicado: (2018)

Evaluating the Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A Randomised Controlled Trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021)

Late Post-Coronavirus Disease 2019 Inflammatory Syndrome: A Case Experience with Tocilizumab
por: Tabarsi, Payam, et al.
Publicado: (2021)

The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review
por: Rezaei, Mitra, et al.
Publicado: (2021)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
por: Malekzadeh, Reza, et al.
Publicado: (2020)

Evaluation of noscapine-licorice combination effects on cough relieving in COVID-19 outpatients: A randomized controlled trial
por: Barati, Saghar, et al.
Publicado: (2023)

Evaluating the Effect of Acetazolamide on the Prevention of Post-operative Acute Kidney Injury after Coronary Artery Bypass Grafting Surgery: A Randomized, Open-labeled Clinical Trial
por: Afzal, Golnaz, et al.
Publicado: (2021)

Simultaneous Determination of Isoniazid, Pyrazinamide and Rifampin in Human Plasma by High-performance Liquid Chromatography and UV Detection
por: Dasht Bozorg, Behnam, et al.
Publicado: (2019)

Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran
por: Baghaei, Parvaneh, et al.
Publicado: (2020)

Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals
por: Marjani, Majid, et al.
Publicado: (2020)

Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infection
por: Tabarsi, Payam, et al.
Publicado: (2011)

Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2022)

COVID-19 in Iran: A model for Crisis Management and Current Experience
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Iran's Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials
por: Rahmanzade, Ramin, et al.
Publicado: (2020)

The Evaluation of Melatonin Effects on Mobilization and Engraftment in Autologous Hematopoietic Stem Cell Transplant Recipients; A Randomized, Double-blind and Placebo-controlled Trial
por: Kazeminia, Neda, et al.
Publicado: (2021)

Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone
por: Sood, Shivani, et al.
Publicado: (2021)

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Efficacy of Early Prone Positioning Combined with Noninvasive Ventilation in COVID-19
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2021)

National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
por: Mirenayat, Maryam Sadat, et al.
Publicado: (2022)

Ciclosporin 10 years on: indications and efficacy
por: Forsythe, Peter, et al.
Publicado: (2014)

Ciclosporin: Various toxicities: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cmi66u7444or6h2gknk87f81h3